220 related articles for article (PubMed ID: 19377885)
1. A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer.
Totani Y; Saito Y; Hayashi M; Tada T; Kohashi Y; Mieno Y; Kato A; Imizu H; Yoneda Y; Hoshino T; Uchiyama Y; Takeuchi Y; Okazawa M; Sakakibara H
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1181-5. PubMed ID: 19377885
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer].
Yumine K; Kawahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():189-92. PubMed ID: 16898000
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
[TBL] [Abstract][Full Text] [Related]
5. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
Ichinose Y; Yoshimori K; Sakai H; Nakai Y; Sugiura T; Kawahara M; Niitani H
Clin Cancer Res; 2004 Dec; 10(23):7860-4. PubMed ID: 15585618
[TBL] [Abstract][Full Text] [Related]
6. [S-1 monotherapy in patients with pretreated advanced non-small cell lung cancer].
Hashizume T; Nakada Y
Gan To Kagaku Ryoho; 2009 Jun; 36(6):963-7. PubMed ID: 19542716
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Ozawa Y; Inui N; Naitoh T; Yasuda K; Nagayama M; Shirai T; Suganuma H; Fujii M; Nakamura H; Suda T; Chida K
Lung Cancer; 2009 Jan; 63(1):68-71. PubMed ID: 18513824
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Imai H; Utsugi M; Iwasaki Y; Shimizu K; Iijima H; Tsurumaki H; Tomizawa Y; Hisada T; Ishizuka T; Saito R; Mori M
Lung Cancer; 2010 May; 68(2):253-7. PubMed ID: 19631403
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer.
Shiroyama T; Komuta K; Imamura F; Hirashima T; Kijima T; Tachibana I; Kawase I
Lung Cancer; 2011 Oct; 74(1):85-8. PubMed ID: 21342712
[TBL] [Abstract][Full Text] [Related]
10. [S-1 activity in non-small cell lung cancer in clinical practice].
Inagaki M; Onuki T; Iguchi K; Ogata T; Hayashi Y; Saito K; Wakai Y; Takabe K; Shinohara Y; Suzuki K; Ohtani T; Horikoshi K
Gan To Kagaku Ryoho; 2009 May; 36(5):763-7. PubMed ID: 19461174
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer.
Wada M; Yamamoto M; Ryuge S; Nagashima Y; Hayashi N; Maki S; Otani S; Katono K; Takakura A; Yanaihara T; Igawa S; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Masuda N
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1005-11. PubMed ID: 22160350
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.
Shirao K; Ohtsu A; Takada H; Mitachi Y; Hirakawa K; Horikoshi N; Okamura T; Hirata K; Saitoh S; Isomoto H; Satoh A
Cancer; 2004 Jun; 100(11):2355-61. PubMed ID: 15160338
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer.
Tamura K; Okamoto I; Ozaki T; Kashii T; Takeda K; Kobayashi M; Matsui K; Shibata T; Kurata T; Nakagawa K; Fukuoka M
Eur J Cancer; 2009 Aug; 45(12):2132-7. PubMed ID: 19409773
[TBL] [Abstract][Full Text] [Related]
15. An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
Naito S; Tsukamoto T; Usami M; Fujimoto H; Akaza H
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1065-70. PubMed ID: 20157711
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Schiller JH; Larson T; Ou SH; Limentani S; Sandler A; Vokes E; Kim S; Liau K; Bycott P; Olszanski AJ; von Pawel J
J Clin Oncol; 2009 Aug; 27(23):3836-41. PubMed ID: 19597027
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group.
Ohtsu A; Baba H; Sakata Y; Mitachi Y; Horikoshi N; Sugimachi K; Taguchi T
Br J Cancer; 2000 Jul; 83(2):141-5. PubMed ID: 10901361
[TBL] [Abstract][Full Text] [Related]
18. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
[TBL] [Abstract][Full Text] [Related]
19. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y
Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
